PSS World Medical (PSSI) has entered into an agreement to distribute Masimo's new Pronto-7 handheld device.
Under the agreement, PSSI will provide access of Pronto-7 to its US customer base of physicians, skilled nursing and assisted living facilities, home health care and hospice agencies, and other alternate site healthcare providers in all 50 states.
The Pronto-7, with dimensions of just 13 cm x 7.2 cm x 2.5 cm, is designed for quick and easy noninvasive spot-checking of total hemoglobin (SpHb), SpO2, pulse rate, and perfusion index in less than one minute.
The device reduces risk of blood contamination, hazardous medical waste, and patient discomfort, associated with traditional blood tests.
Masimo sales marketing and clinical research president Jon Coleman said, "With the full market release of our breakthrough noninvasive hemoglobin monitoring products, we can leverage the sales footprint and customer relationships of PSS's professional field sales team to drive awareness of noninvasive hemoglobin technology and how doctors can use it to revolutionize their medical practices."
